HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,632 | -27.9% | 43,144 | -24.4% | 0.00% | – |
| Q1 2023 | $42,479 | +32.7% | 57,080 | +71.1% | 0.00% | – |
| Q3 2022 | $32,000 | -13.5% | 33,361 | +73.6% | 0.00% | – |
| Q2 2022 | $37,000 | -95.8% | 19,212 | -83.6% | 0.00% | -100.0% |
| Q4 2021 | $887,000 | -72.4% | 117,442 | -71.1% | 0.00% | -71.4% |
| Q3 2021 | $3,211,000 | +556.6% | 406,470 | +1311.4% | 0.01% | +250.0% |
| Q3 2020 | $489,000 | +1.5% | 28,800 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $482,000 | +3.4% | 29,022 | -27.9% | 0.00% | -50.0% |
| Q1 2020 | $466,000 | -20.3% | 40,232 | +1.7% | 0.00% | +100.0% |
| Q4 2019 | $585,000 | – | 39,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |